Expertise in
2
conditions

Mingfang Ji

Zhongshan, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Zhongshan, CN 

Overview

Mingfang Ji practices practicing medicine in Zhongshan, China.

Ji is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Nasopharyngeal Carcinoma, Mononucleosis, and Liver Cancer.

They are actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 4 clinical trials.

Locations

Zhongshan, China
Other Locations
Zhanjiang, 528023, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Searching for Early Detection Biomarkers of Nasopharyngeal Carcinoma in Zhongshan City
Searching for Early Detection Biomarkers of Nasopharyngeal Carcinoma in Zhongshan City
Enrollment Status: Recruiting
Publish Date: July 13, 2023
Intervention Type: Diagnostic test, Biological
Serology Screening Test for the Detection of Nasopharyngeal Carcinoma in Zhongshan City
Serology Screening Test for the Detection of Nasopharyngeal Carcinoma in Zhongshan City
Enrollment Status: Unknown
Publish Date: July 13, 2023
Searching for Early Detection Biomarkers and to Reduce Mortality Rate of Hepatocellular Cancer (HCC) in Zhongshan City
Searching for Early Detection Biomarkers and to Reduce Mortality Rate of Hepatocellular Cancer (HCC) in Zhongshan City
Enrollment Status: Unknown
Publish Date: July 13, 2023
Intervention Type: Biological
A Cluster Randomized Controlled Screening Trial for Nasopharyngeal Carcinoma in Southern China (CRCSTNPC Study)
A Cluster Randomized Controlled Screening Trial for Nasopharyngeal Carcinoma in Southern China (CRCSTNPC Study)
Enrollment Status: Unknown
Publish Date: February 28, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 3 Less Clinical Trials

36 Total Publications

Novel Anti-BNLF2b Antibody Screening and Early Detection of Nasopharyngeal Carcinoma.
Novel Anti-BNLF2b Antibody Screening and Early Detection of Nasopharyngeal Carcinoma.
Journal: JAMA otolaryngology-- head & neck surgery
Published: May 21, 2026

Frequently Asked Questions about Mingfang Ji

Is Mingfang Ji a top-rated expert for Nasopharyngeal Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Mingfang Ji is classified as an Distinguished expert for Nasopharyngeal Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mingfang Ji participate in research or clinical trials?

Yes. Mingfang Ji has published 36 articles and abstracts on conditions like Nasopharyngeal Carcinoma. You can view a list of Mingfang Ji's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ji's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile